Drug Type Synthetic peptide |
Synonyms AEM 28 |
Target |
Mechanism APOE agonists(Apolipoprotein E agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization ![]() |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperlipidemia Type IIa | Phase 2 | AU | 26 May 2014 | |
Hypercholesterolemia | Phase 2 | AU | 23 May 2014 | |
Hyperlipoproteinemia Type II | Phase 2 | AU | 01 Mar 2014 |
Phase 1/2 | 52 | (AEM-28) | ordywttodg(kcbtdlefrx) = tlcfncymnj miukfdykfc (fskvkojctx, uxdnbwpwwa - iqxohmpgbt) View more | - | 29 Dec 2015 | ||
(Normal Saline) | ordywttodg(kcbtdlefrx) = efcsmcnjer miukfdykfc (fskvkojctx, whlgmeaely - teunjgalsx) View more |